All stock lists
Cartesian Growth Corp II (RENE)
United States · Delayed Price · Currency is USD
Financial Services
—
Insider Score
| Market Cap | n/a |
| Revenue (ttm) | n/a |
| Net Income | n/a |
| EPS | n/a |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Open | n/a |
| Previous Close | n/a |
| Day's Range | n/a |
| 52-Week Range | n/a |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
No price history available.
$RENE stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in RENE holdings by institutional investors
Scanning latest 13F filings…
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by RENE's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
RENE Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New RENE patent grants
Loading patent grants…
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to RENE from public contracts
Source: USAspending.gov
Bull Case vs Bear Case
AI-generated from RENE’s recent data — informational, not investment advice
Generating analysis…
What’s Behind the Score
Insider Activity
No data yet
—
Analyst Ratings
No data yet
—
News & Sentiment
100% of score
35
News check: Q3 earnings miss on both revenue and estimates, with covenant relief and project delays cited as headwinds offsetting any revenue growth.
Recent Insider Activity
Buys
0
Sells
0
Buy Value
$0
Distinct Buyers
0
Frequently Asked Questions
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.
